Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Uncovering Surgical Dynamics and Trends in Early Breast Cancer Stage at Diagnosis: Key Insights From a Two-Decade Argentine Database Analysis.
Mandó P, Fabiano V, Gomez Guasch S, Colucci G, Sánchez-Bayona R, Coló F, Loza M, Von Stecher F, Amat M, de la Vega M, Costanzo MV, Nervo A, Nadal J, Chacón R, Perazzo F; RCM Database Contributors. Mandó P, et al. Among authors: chacon r. JCO Glob Oncol. 2024 Nov;10:e2400123. doi: 10.1200/GO.24.00123. Epub 2024 Nov 27. JCO Glob Oncol. 2024. PMID: 39602672
Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database.
Fabiano V, Mandó P, Rizzo M, Ponce C, Coló F, Loza M, Loza J, Amat M, Mysler D, Costanzo MV, Nervo A, Nadal J, Perazzo F, Chacón R; RCM Database Contributors4. Fabiano V, et al. Among authors: chacon r. JCO Glob Oncol. 2020 Apr;6:639-646. doi: 10.1200/JGO.19.00228. JCO Glob Oncol. 2020. PMID: 32315233 Free PMC article.
Cyclin-Dependent Kinase 4/6 Inhibitor Outcomes in Patients With Advanced Breast Cancer Carrying Germline Pathogenic Variants in DNA Repair-Related Genes.
Bruno L, Ostinelli A, Waisberg F, Enrico D, Ponce C, Rivero S, Blanco A, Zarba M, Loza M, Fabiano V, Amat M, Pombo MT, Noro L, Chacón M, Coló F, Chacón R, Nadal J, Nervo A, Costanzo V. Bruno L, et al. Among authors: chacon r, chacon m. JCO Precis Oncol. 2022 Mar;6:e2100140. doi: 10.1200/PO.21.00140. JCO Precis Oncol. 2022. PMID: 35235412
Triple-negative breast cancer.
Chacón RD, Costanzo MV. Chacón RD, et al. Breast Cancer Res. 2010;12 Suppl 2(Suppl 2):S3. doi: 10.1186/bcr2574. Epub 2010 Oct 22. Breast Cancer Res. 2010. PMID: 21050424 Free PMC article. Review.
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients.
Roberti MP, Rocca YS, Amat M, Pampena MB, Loza J, Coló F, Fabiano V, Loza CM, Arriaga JM, Bianchini M, Barrio MM, Bravo AI, Domenichini E, Chacón R, Mordoh J, Levy EM. Roberti MP, et al. Among authors: chacon r. Breast Cancer Res Treat. 2012 Dec;136(3):659-71. doi: 10.1007/s10549-012-2287-y. Epub 2012 Oct 14. Breast Cancer Res Treat. 2012. PMID: 23065032
Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice.
Solano AR, Cardoso FC, Romano V, Perazzo F, Bas C, Recondo G, Santillan FB, Gonzalez E, Abalo E, Viniegra M, Michel JD, Nuñez LM, Noblia CM, Mc Lean I, Canton ED, Chacon RD, Cortese G, Varela EB, Greco M, Barrientos ML, Avila SA, Vuotto HD, Lorusso A, Podesta EJ, Mando OG. Solano AR, et al. Oncotarget. 2016 Jul 24;8(36):60487-60495. doi: 10.18632/oncotarget.10814. eCollection 2017 Sep 1. Oncotarget. 2016. PMID: 28947987 Free PMC article.
181 results